{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:26:03Z","timestamp":1784366763385,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The S\uff06T Program of Hebei","award":["No.22377728D"],"award-info":[{"award-number":["No.22377728D"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-90778-7","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T04:24:55Z","timestamp":1739939095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association between blood eosinophil levels and prognosis in critically ill patients with different heart failure phenotypes"],"prefix":"10.1038","volume":"15","author":[{"given":"Chengjian","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angwei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangtian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaidan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"issue":"17","key":"90778_CR1","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2023","unstructured":"Savarese, G. et al. Global burden of heart failure: A comprehensive and updated review of epidemiology. Cardiovasc. Res. 118(17), 3272\u20133287 (2023).","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"90778_CR2","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt, B. et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart failure: endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese heart failure Association. Eur. J. Heart Fail. 23(3), 352\u2013380 (2021).","journal-title":"Eur. J. Heart Fail."},{"key":"90778_CR3","unstructured":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 392(10159), 1789\u20131858. (2018)."},{"issue":"15","key":"90778_CR4","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1093\/eurjpc\/zwaa147","volume":"28","author":"NL Bragazzi","year":"2021","unstructured":"Bragazzi, N. L. et al. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. Eur. J. Prev. Cardiol. 28(15), 1682\u20131690 (2021).","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"10","key":"90778_CR5","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","volume":"128","author":"VL Roger","year":"2021","unstructured":"Roger, V. L. Epidemiology of Heart failure: A contemporary perspective. Circ. Res. 128(10), 1421\u20131434 (2021).","journal-title":"Circ. Res."},{"issue":"8","key":"90778_CR6","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/ejhf.1858","volume":"22","author":"A Groenewegen","year":"2020","unstructured":"Groenewegen, A. et al. Epidemiology of heart failure. Eur. J. Heart Fail. 22(8), 1342\u20131356 (2020).","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"90778_CR7","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.1016\/S2214-109X(20)30004-8","volume":"8","author":"J Tromp","year":"2020","unstructured":"Tromp, J. et al. Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): A cohort study. Lancet Glob Health. 8(3), e411\u2013e422 (2020).","journal-title":"Lancet Glob Health"},{"issue":"26","key":"90778_CR8","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1093\/eurheartj\/ehz158","volume":"40","author":"F Triposkiadis","year":"2019","unstructured":"Triposkiadis, F. et al. The continuous heart failure spectrum: Moving beyond an ejection fraction classification. Eur. Heart J. 40(26), 2155\u20132163 (2019).","journal-title":"Eur. Heart J."},{"key":"90778_CR9","doi-asserted-by":"crossref","unstructured":"Borlaug, B. A. & Redfield, M. M. Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation 123(18): (2011). 2006-13; discussion 2014.","DOI":"10.1161\/CIRCULATIONAHA.110.954388"},{"issue":"10","key":"90778_CR10","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1161\/CIRCRESAHA.121.318159","volume":"128","author":"WJ Paulus","year":"2021","unstructured":"Paulus, W. J. & Zile, M. R. From systemic inflammation to myocardial fibrosis: The heart failure with preserved ejection Fraction paradigm revisited. Circ. Res. 128(10), 1451\u20131467 (2021).","journal-title":"Circ. Res."},{"issue":"5","key":"90778_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","volume":"17","author":"L Adamo","year":"2020","unstructured":"Adamo, L. et al. Reappraising the role of inflammation in heart failure. Nat. Rev. Cardiol. 17(5), 269\u2013285 (2020).","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"90778_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/CIRCRESAHA.116.308030","volume":"119","author":"SA Dick","year":"2016","unstructured":"Dick, S. A. & Epelman, S. Chronic heart failure and inflammation: What do we really know? Circ. Res. 119(1), 159\u2013176 (2016).","journal-title":"Circ. Res."},{"key":"90778_CR13","doi-asserted-by":"crossref","unstructured":"Tang, X. et al. KLF2 regulates neutrophil activation and thrombosis in cardiac hypertrophy and heart failure progression. J. Clin. Invest. 132(3). (2022).","DOI":"10.1172\/JCI147191"},{"issue":"8","key":"90778_CR14","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41591-018-0059-x","volume":"24","author":"G Bajpai","year":"2018","unstructured":"Bajpai, G. et al. The human heart contains distinct macrophage subsets with divergent origins and functions. Nat. Med. 24(8), 1234\u20131245 (2018).","journal-title":"Nat. Med."},{"issue":"2","key":"90778_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/eci.12023","volume":"43","author":"BJ Wrigley","year":"2013","unstructured":"Wrigley, B. J. et al. CD14\u2009+\u2009+\u2009CD16\u2009+\u2009monocytes in patients with acute ischaemic heart failure. Eur. J. Clin. Invest. 43(2), 121\u2013130 (2013).","journal-title":"Eur. J. Clin. Invest."},{"issue":"10","key":"90778_CR16","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1161\/CIRCULATIONAHA.121.055888","volume":"145","author":"G Feng","year":"2022","unstructured":"Feng, G. et al. CCL17 aggravates myocardial injury by suppressing recruitment of regulatory T cells. Circulation 145(10), 765\u2013782 (2022).","journal-title":"Circulation"},{"key":"90778_CR17","doi-asserted-by":"publisher","first-page":"p9095275","DOI":"10.1155\/2018\/9095275","volume":"2018","author":"GA Ramirez","year":"2018","unstructured":"Ramirez, G. A. et al. Eosinophils from physiology to disease: A comprehensive review. Biomed. Res. Int. 2018, p9095275 (2018).","journal-title":"Biomed. Res. Int."},{"issue":"21","key":"90778_CR18","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1182\/blood.2019000518","volume":"134","author":"C Marx","year":"2019","unstructured":"Marx, C. et al. Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps. Blood 134(21), 1859\u20131872 (2019).","journal-title":"Blood"},{"issue":"1","key":"90778_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/cvr\/cvac060","volume":"119","author":"C Yang","year":"2023","unstructured":"Yang, C. et al. Eosinophils protect pressure overload- and \u03b2-adrenoreceptor agonist-induced cardiac hypertrophy. Cardiovasc. Res. 119(1), 195\u2013212 (2023).","journal-title":"Cardiovasc. Res."},{"key":"90778_CR20","doi-asserted-by":"publisher","first-page":"951","DOI":"10.2147\/CIA.S413313","volume":"18","author":"W Wen","year":"2023","unstructured":"Wen, W. et al. The predictive values of White Blood Cell Indices (lymphocyte and Eosinophilic Granulocyte) for heart failure in Acute Coronary Syndrome patients following percutaneous coronary intervention: A prospective cohort study. Clin. Interv Aging 18, 951\u2013962 (2023).","journal-title":"Clin. Interv Aging"},{"issue":"2","key":"90778_CR21","doi-asserted-by":"publisher","first-page":"e000477","DOI":"10.1136\/openhrt-2016-000477","volume":"3","author":"AD Shah","year":"2016","unstructured":"Shah, A. D. et al. Low eosinophil and low lymphocyte counts and the incidence of 12 cardiovascular diseases: A CALIBER cohort study. Open. Heart 3(2), e000477 (2016).","journal-title":"Open. Heart"},{"issue":"4","key":"90778_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/MEJ.0b013e32834c67eb","volume":"19","author":"MA Cikrikcioglu","year":"2012","unstructured":"Cikrikcioglu, M. A. et al. Absolute blood eosinophil count and 1-year mortality risk following hospitalization with acute heart failure. Eur. J. Emerg. Med. 19(4), 257\u2013263 (2012).","journal-title":"Eur. J. Emerg. Med."},{"key":"90778_CR23","doi-asserted-by":"crossref","unstructured":"Vural, A. & Ayd\u0131n, E. The predictive value of Eosinophil Indices for Major Cardiovascular Events in patients with Acute Decompensated HFrEF. Med. (Kaunas) 58(10). (2022).","DOI":"10.3390\/medicina58101455"},{"key":"90778_CR24","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.2147\/JIR.S325229","volume":"14","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. Relationship between the Eosinophil\/Monocyte ratio and prognosis in Decompensated Heart failure: A retrospective study. J. Inflamm. Res. 14, 4687\u20134696 (2021).","journal-title":"J. Inflamm. Res."},{"issue":"1","key":"90778_CR25","doi-asserted-by":"publisher","first-page":"160035","DOI":"10.1038\/sdata.2016.35","volume":"3","author":"AEW Johnson","year":"2016","unstructured":"Johnson, A. E. W. et al. MIMIC-III, a freely accessible critical care database. Sci. Data. 3 (1), 160035 (2016).","journal-title":"Sci. Data"},{"issue":"7","key":"90778_CR26","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.cardfail.2022.02.015","volume":"28","author":"JC Jentzer","year":"2022","unstructured":"Jentzer, J. C. et al. Outcomes and predictors of mortality among cardiac intensive care unit patients with heart failure. J. Card Fail. 28(7), 1088\u20131099 (2022).","journal-title":"J. Card Fail."},{"issue":"4","key":"90778_CR27","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrcardio.2015.14","volume":"12","author":"SJ Greene","year":"2015","unstructured":"Greene, S. J. et al. The vulnerable phase after hospitalization for heart failure. Nat. Rev. Cardiol. 12(4), 220\u2013229 (2015).","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"90778_CR28","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ahj.2014.07.008","volume":"168","author":"RK Cheng","year":"2014","unstructured":"Cheng, R. K. et al. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. Am. Heart J. 168(5), 721\u2013730 (2014).","journal-title":"Am. Heart J."},{"issue":"20","key":"90778_CR29","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","volume":"70","author":"KS Shah","year":"2017","unstructured":"Shah, K. S. et al. Heart failure with preserved, Borderline, and reduced ejection fraction: 5-Year outcomes. J. Am. Coll. Cardiol. 70(20), 2476\u20132486 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"90778_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1056\/NEJMoa052256","volume":"355","author":"TE Owan","year":"2006","unstructured":"Owan, T. E. et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl. J. Med. 355(3), 251\u2013259 (2006).","journal-title":"N Engl. J. Med."},{"key":"90778_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cca.2018.06.021","volume":"485","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. Prognostic value of neutrophil to lymphocyte ratio in heart failure patients. Clin. Chim. Acta. 485, 44\u201349 (2018).","journal-title":"Clin. Chim. Acta"},{"key":"90778_CR32","doi-asserted-by":"publisher","first-page":"1005697","DOI":"10.3389\/fimmu.2022.1005697","volume":"13","author":"X Zhu","year":"2022","unstructured":"Zhu, X. et al. Long-term prognostic value of inflammatory biomarkers for patients with acute heart failure: Construction of an inflammatory prognostic scoring system. Front. Immunol. 13, 1005697 (2022).","journal-title":"Front. Immunol."},{"issue":"9","key":"90778_CR33","doi-asserted-by":"publisher","first-page":"e1027","DOI":"10.1002\/iid3.1027","volume":"11","author":"Q Pan","year":"2023","unstructured":"Pan, Q. et al. Development of heart failure with preserved ejection fraction is independent of eosinophils in a preclinical model. Immun. Inflamm. Dis. 11(9), e1027 (2023).","journal-title":"Immun. Inflamm. Dis."},{"issue":"16","key":"90778_CR34","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1161\/CIRCULATIONAHA.105.587519","volume":"113","author":"L van Heerebeek","year":"2006","unstructured":"van Heerebeek, L. et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 113(16), 1966\u20131973 (2006).","journal-title":"Circulation"},{"issue":"4","key":"90778_CR35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus, W. J. & Tsch\u00f6pe, C. A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J. Am. Coll. Cardiol. 62(4), 263\u2013271 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"90778_CR36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.pcad.2005.02.006","volume":"47","author":"MR Zile","year":"2005","unstructured":"Zile, M. R., Baicu, C. F. & Bonnema, D. D. Diastolic heart failure: Definitions and terminology. Prog Cardiovasc. Dis. 47(5), 307\u2013313 (2005).","journal-title":"Prog Cardiovasc. Dis."},{"issue":"1 Suppl","key":"90778_CR37","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1097\/01.CCM.0000296267.84202.B0","volume":"36","author":"K Chatterjee","year":"2008","unstructured":"Chatterjee, K. & Rame, J. E. Systolic heart failure: Chronic and acute syndromes. Crit. Care Med. 36(1 Suppl), S44\u201351 (2008).","journal-title":"Crit. Care Med."},{"issue":"9","key":"90778_CR38","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1093\/cvr\/cvab237","volume":"118","author":"JY Xu","year":"2022","unstructured":"Xu, J. Y. et al. Interleukin-5-induced eosinophil population improves cardiac function after myocardial infarction. Cardiovasc. Res. 118(9), 2165\u20132178 (2022).","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"90778_CR39","doi-asserted-by":"publisher","first-page":"6396","DOI":"10.1038\/s41467-020-19297-5","volume":"11","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. Eosinophils improve cardiac function after myocardial infarction. Nat. Commun. 11(1), 6396 (2020).","journal-title":"Nat. Commun."},{"issue":"7","key":"90778_CR40","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jacbts.2020.05.005","volume":"5","author":"IS Toor","year":"2020","unstructured":"Toor, I. S. et al. Eosinophil Deficiency promotes aberrant repair and adverse remodeling following Acute myocardial infarction. JACC Basic. Transl Sci. 5(7), 665\u2013681 (2020).","journal-title":"JACC Basic. Transl Sci."},{"issue":"2","key":"90778_CR41","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1161\/CIRCRESAHA.120.318182","volume":"128","author":"CL Liu","year":"2021","unstructured":"Liu, C. L. et al. Eosinophils protect mice from Angiotensin-II Perfusion-Induced Abdominal aortic aneurysm. Circ. Res. 128(2), 188\u2013202 (2021).","journal-title":"Circ. Res."},{"issue":"3","key":"90778_CR42","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/heartjnl-2020-317202","volume":"108","author":"A Bondue","year":"2022","unstructured":"Bondue, A., Carpentier, C. & Roufosse, F. Hypereosinophilic syndrome: Considerations for the cardiologist. Heart 108(3), 164\u2013171 (2022).","journal-title":"Heart"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90778-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90778-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90778-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T04:25:06Z","timestamp":1739939106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90778-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["90778"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-90778-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"23 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6008"}}